MOR Annual CAPEX
$3.11 M
-$12.95 M-80.64%
31 December 2023
Summary:
As of February 5, 2025, MOR annual capital expenditures is $3.11 million, with the most recent change of -$12.95 million (-80.64%) on December 31, 2023. During the last 3 years, it has fallen by -$53.23 million (-94.48%).MOR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR Quarterly CAPEX
N/A
31 December 2023
Summary:
MOR quarterly capital expenditures is not available.MOR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR TTM CAPEX
N/A
31 December 2023
Summary:
MOR TTM capital expenditures is not available.MOR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MOR CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -80.6% | - | - |
| 3 y3 years | -94.5% | - | - |
| 5 y5 years | +6.8% | - | - |
MOR CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -94.5% |
MorphoSys AG CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $3.11 M(-80.6%) | - | - |
| June 2023 | - | $118.30 K(-74.0%) | $573.80 K(-86.2%) |
| Mar 2023 | - | $455.50 K(-87.7%) | $4.17 M(-80.2%) |
| Dec 2022 | $16.06 M(-48.1%) | - | - |
| June 2022 | - | $3.71 M(+182.5%) | $21.00 M(-32.8%) |
| Mar 2022 | - | $1.31 M(-87.8%) | $31.26 M(+1.0%) |
| Dec 2021 | $30.95 M(-45.1%) | $10.80 M(+108.5%) | $30.95 M(-8.1%) |
| Sept 2021 | - | $5.18 M(-62.9%) | $33.67 M(-40.9%) |
| June 2021 | - | $13.97 M(+1300.4%) | $56.94 M(-0.7%) |
| Mar 2021 | - | $997.70 K(-92.6%) | $57.34 M(+1.8%) |
| Dec 2020 | $56.34 M(+1273.0%) | $13.52 M(-52.5%) | $56.34 M(+29.5%) |
| Sept 2020 | - | $28.45 M(+98.0%) | $43.50 M(+156.3%) |
| June 2020 | - | $14.37 M(+2020.9%) | $16.98 M(+313.7%) |
| Dec 2019 | $4.10 M(+41.0%) | $677.60 K(-64.8%) | $4.10 M(-15.2%) |
| Sept 2019 | - | $1.93 M(+68.9%) | $4.84 M(+40.2%) |
| June 2019 | - | $1.14 M(+217.8%) | $3.45 M(+25.7%) |
| Mar 2019 | - | $359.00 K(-74.6%) | $2.75 M(-5.7%) |
| Dec 2018 | $2.91 M(-80.5%) | $1.41 M(+163.1%) | $2.91 M(+91.9%) |
| Sept 2018 | - | $537.50 K(+23.6%) | $1.52 M(-89.7%) |
| June 2018 | - | $434.80 K(-17.2%) | $14.70 M(-0.7%) |
| Mar 2018 | - | $524.90 K(+2551.0%) | $14.81 M(-0.6%) |
| Dec 2017 | $14.89 M(+361.8%) | $19.80 K(-99.9%) | $14.89 M(-11.2%) |
| Sept 2017 | - | $13.72 M(+2427.4%) | $16.77 M(+345.0%) |
| June 2017 | - | $542.90 K(-10.6%) | $3.77 M(+10.7%) |
| Mar 2017 | - | $607.30 K(-68.0%) | $3.40 M(+5.5%) |
| Dec 2016 | $3.22 M(-66.9%) | $1.90 M(+163.4%) | $3.22 M(+68.3%) |
| Sept 2016 | - | $720.50 K(+305.9%) | $1.92 M(-52.4%) |
| June 2016 | - | $177.50 K(-58.6%) | $4.02 M(-6.0%) |
| Mar 2016 | - | $428.70 K(-27.2%) | $4.28 M(-56.0%) |
| Dec 2015 | $9.73 M | $588.80 K(-79.2%) | $9.73 M(-15.9%) |
| Sept 2015 | - | $2.83 M(+549.1%) | $11.57 M(-62.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $435.40 K(-92.6%) | $30.78 M(-1.5%) |
| Mar 2015 | - | $5.88 M(+141.9%) | $31.25 M(+14.8%) |
| Dec 2014 | $27.23 M(+268.6%) | $2.43 M(-89.0%) | $27.23 M(+3.5%) |
| Sept 2014 | - | $22.04 M(+2323.4%) | $26.30 M(+428.5%) |
| June 2014 | - | $909.30 K(-51.1%) | $4.98 M(-40.4%) |
| Mar 2014 | - | $1.86 M(+24.1%) | $8.35 M(+13.0%) |
| Dec 2013 | $7.39 M(+148.7%) | $1.50 M(+110.6%) | $7.39 M(+5.6%) |
| Sept 2013 | - | $711.30 K(-83.4%) | $6.99 M(+1.5%) |
| June 2013 | - | $4.29 M(+379.3%) | $6.89 M(+139.6%) |
| Mar 2013 | - | $894.10 K(-19.0%) | $2.88 M(-3.2%) |
| Dec 2012 | $2.97 M(-40.9%) | $1.10 M(+81.7%) | $2.97 M(-7.9%) |
| Sept 2012 | - | $607.30 K(+124.7%) | $3.23 M(-12.2%) |
| June 2012 | - | $270.30 K(-72.7%) | $3.67 M(-24.0%) |
| Mar 2012 | - | $990.00 K(-27.2%) | $4.83 M(-3.9%) |
| Dec 2011 | $5.03 M(-72.5%) | $1.36 M(+29.0%) | $5.03 M(-8.5%) |
| Sept 2011 | - | $1.05 M(-26.2%) | $5.50 M(-4.1%) |
| June 2011 | - | $1.43 M(+20.6%) | $5.73 M(-68.3%) |
| Mar 2011 | - | $1.18 M(-35.2%) | $18.09 M(-1.2%) |
| Dec 2010 | $18.31 M(+243.8%) | $1.83 M(+41.8%) | $18.31 M(+0.5%) |
| Sept 2010 | - | $1.29 M(-90.6%) | $18.22 M(-5.3%) |
| June 2010 | - | $13.79 M(+883.7%) | $19.25 M(+203.3%) |
| Mar 2010 | - | $1.40 M(-19.5%) | $6.34 M(+19.2%) |
| Dec 2009 | $5.32 M(-6.6%) | $1.74 M(-24.9%) | $5.32 M(+48.6%) |
| Sept 2009 | - | $2.32 M(+162.0%) | $3.58 M(+183.2%) |
| June 2009 | - | $884.90 K(+132.6%) | $1.27 M(+232.6%) |
| Mar 2009 | - | $380.40 K | $380.40 K |
| Dec 2008 | $5.70 M(-65.4%) | - | - |
| Dec 2007 | $16.46 M(+666.5%) | - | - |
| Dec 2004 | $2.15 M(+158.0%) | - | - |
| Dec 2003 | $832.30 K(-4.5%) | - | - |
| Dec 2002 | $871.80 K | - | - |
FAQ
- What is MorphoSys AG annual capital expenditures?
- What is the all time high annual CAPEX for MorphoSys AG?
- What is MorphoSys AG annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for MorphoSys AG?
- What is the all time high TTM CAPEX for MorphoSys AG?
What is MorphoSys AG annual capital expenditures?
The current annual CAPEX of MOR is $3.11 M
What is the all time high annual CAPEX for MorphoSys AG?
MorphoSys AG all-time high annual capital expenditures is $56.34 M
What is MorphoSys AG annual CAPEX year-on-year change?
Over the past year, MOR annual capital expenditures has changed by -$12.95 M (-80.64%)
What is the all time high quarterly CAPEX for MorphoSys AG?
MorphoSys AG all-time high quarterly capital expenditures is $28.45 M
What is the all time high TTM CAPEX for MorphoSys AG?
MorphoSys AG all-time high TTM capital expenditures is $57.34 M